Skip to main content
. 2021 Jan 19:dkaa563. doi: 10.1093/jac/dkaa563

Table 1.

Patients identified in each diagnostic group at RFH and BH

Royal Free Hospital
Barnet Hospital
Diagnosis CAP (n = 106) COVID-19 (n = 619) P value CAP (n = 169) COVID-19 (n = 181) P value
Chest radiograph, n (%)a
 Lobar consolidation 106 (100) 4 (0.6) 169 (100) 0 (0%)
 CVXC0 62 (10.0) 22 (12.2)
 CVCX1 281 (45.3) 71 (39.2)
 CVCX2 136 (22.0) 36 (19.9)
 CVCX3 17 (2.7) 5 (2.8)
 Ungraded 123 (19.9) 47 (26.0)
Male, n (%) 50 (47) 386 (62) 0.0037 81 (47.9) 104 (57.5) 0.0865
Age, years, median (range) 72 (19–99) 68 (18–100) 0.1401 74 (18–98) 71 (29–98) 0.0633
Ethnicity, n (%) 0.0007 0.0335
 White 60 (57) 250 (40) 128 (76) 115 (64)
 Asian 23 (22) 83 (13) 11 (7) 26 (14)
 Black 6 (6) 69 (11) 1 (1) 11 (6)
 Mixed 2 (2) 7 (1) 0 (0) 2 (1)
 Other/unknown 15 (14) 210 (34) 29 (17) 27 (15)
Charlson index co- morbidities n (%) <0.0001 0.0206
 0 18 (17) 243 (39) 51 (30) 81 (45)
 1 33 (31) 190 (31) 51 (30) 58 (32)
 2 28 (26) 109 (18) 35 (21) 23 (13)
 3+ 27 (25) 77 (13) 32 (19) 19 (10)
Patients with microbiological identification of bacteria, n (%) 15 (14.2) 26 (4.2) 0.0003 15 (8.9) 10 (5.5) 0.2992
Microbiology results, n (%)
 Sputum 6 (5.7) 8 (1.3) 2 (1.2) 5 (2.8)
 Blood 2 (1.9) 12 (1.9) 6 (3.6) 5 (2.8)
 Urine Ag 4 (3.8) 3 (0.5) 8 (4.7) 0 (0.0)
 Mycoplasma PCR 5 (4.7) 3 (0.5) 0 (0.0) 0 (0.0)
Blood samples collected 48–72 h into admission, n (%) 53 (50.0) 331 (53.5) 99 (58.6) 60 (33.1)

P values represent comparisons between CAP and COVID-19 and each hospital site. Comparisons between the cohorts at each hospital site were performed by Mann–Whitney test for age, by Fisher’s exact test for gender, and by Chi-square test for ethnicity, Charlson co-morbidities and microbiological results. P values represent comparisons between CAP and COVID-19 and each hospital site.

Chest radiograph codes for COVID-19 patients based on British Society of Thoracic Imaging guidelines: CVCX0 = Normal; CVCX1 = Classic for COVID-19; CVCX2 = Indeterminate for COVID-19; CVCX3 = Non-COVID-19.